Biography
Dr. Olinger is a microbiologist and immunologist with a focus on human infectious diseases. Dr. Olinger is the current lead for the NIAID TBQA program for the past three years. Dr. Olinger oversees efforts to develop medical countermeasures, including novel diagnostics for various pathogens. He has extensive experience in clinical microbiology and currently teaches applied courses for nurses and other clinicians for clinical microbiology. Dr. Olinger has experience in cGMP and cGLP within high and maximum containment and is serving as a CDC Technical Advisor for public health laboratories which involve both CLIA and CAP requirements. He has supported epidemiological analysis for purposes of infection control in a clinical and non-clinical setting and for investigation of potential outbreaks. He has also been deployed to establish and manage diagnostic capabilities in resource limited conditions for outbreaks.
Dr. Olinger has conducted, managed, and overseen multiple contracts and research agreements with both domestic and international partners. He has the proven expertise, leadership, training, and drive necessary to build and sustain collaborative studies. Within the laboratory setting his considerable experience conducting in vitro and in vivo experiments in biocontainment, with more than 20 years of BSL-3 & BSL-4 experience.
Dr. Olinger is equally comfortable as a team member or team lead in international collaborations. His love of science, finding solutions, and seeking disruptive innovation that improve the wellbeing of others and reduce the risk of the world to infectious diseases are his focus. For almost a decade, he has been overseeing strategic planning initiatives, budget administration, and program development to improve overall performance. From conceptualizing and establishing forward-thinking plans and programs to recruiting, training, and motivating outstanding team members, he excels at directing strategic enhancements to drive goal achievement while communicating openly and routinely with internal and external stakeholders.